Hubungan Hs-Crp Dengan Ketebalan Tunikaintima Media Arteri Karotis Komunis Berdasarkan Pemeriksaan Usg Pada Penderita Angina Pektoris Stabil
49
DAFTAR PUSTAKA
1. Riskesdas 2007, Badan penelitian dan Pengembangan kesehatan
Departemen Kesehatan Republik Indonesia: Desember 2008.
2. Goran
K.
Hansson. Inflammation,
Atherosclerosis, and
Coronary
ArteryDisease. N Engl J Med 2005; 352: 1685-95.
3. Thomas A. Pearson, George A. Mensah. Markers of Inflammation
andCardiovascular Disease. Application to Clinical and Public Health
Practice. A Statement for Health care Professionals From the Centers for
Disease Control and Prevention and the American Heart Association.
AHA/CDC Scientific Statement. Circulation. 2003;107:499-511.
4. Syed Shahid Habib, Level of high-sensitivity c-reactive protein in Saudi
patients with chronic stable coronary artery disease. Department of
Physiology, College ofMedicine, King SaudiUniversity, Riyadh, Kingdom
of Saudi Arabia J Ayub Med Coll Abbottabad 2008;20(2).
5. Hansa, Gupta, Bhargava, Kartikeya, Bansal, Manish. Carotid IntimaMedia Thickness and Coronary Artery Disease: an Indian Perspective
[internet]. Asian Cardiovasc Thorac Ann. 2003 [diakses Januari 2012];
11:217221.Dari:http://asianannals.ctsnetjournals.org/cgi/content/full/11/3/217.
6. Kafetzakis, Alexandros, Kochiadakis, George and Lailotis, Anggelos.
Association of Subclinical Wall Changes of Carotid, Femoral, and
Popliteal Arteries With Obstructive Coronary Artery Disease in Patients
Undergoing Coronary Angiography [internet]. Chest. 2005 [diakses
Universitas Sumatera Utara
50
Januari2012].
128(4):2538-
43.Dari:http://chestjournal.chestpubs.org/content/128/4/2538.long.
7. Chien KL et all. Carotid Artery Intima-Media Thickness, Carotid Plaque
and Coronary Heart Disease and Stroke in Chinese. PloS ONE. Available
at: http//www.plosone.org. October 2008. Volume 3. Issue 10. E3435.
8. Chan SY et all. The Prognostic Importance of Endothelial Dysfunction and
Carotid Atheroma Burden in Patients with Coronary Artery Disease. J Am
Coll Cardiol 2003, 42:1037-1043.
9. Mirna M, Bachtiar M. Peranan Ultrasonografi dalam menilai kompleks
Intima-Media Arteri Karotis untuk diagnosis dini Aterosklerosis. Bagian
Radiologi FK Hasanuddin. Makasar. CDK 184/vol.38 no.3/April 2011.
10. Bratawidjaja KG. Imunologi Dasar. Gaya Baru. Edisi ke-7. Jakarta, 2006.
Hal. 13-15, 391-408.
11. Khera A. Biomarkers in Heart Diseases. In: Lemos JA (Ed). Biomarkers
in
Heart
Disease.
BlackWell
Publishing.
1st
Edition.
Massachussetts,2008,p.161-180.
12. Capuzzi DM, Freeman JS. C-Reactive Protein and Cardiovascular Risk in
the Metabolic Syndrome and Type 2 Diabetes, Clinical Diabetes, Vol.25,
2007, p. 16-22.
13. Lei KJ, Liu T, Zon G, Soravia E, Liu TY, Goldman ND. Genomic DNA
sequence for human C-reactive protein. J Biol Chem 1985;260:13377–83.
14. Pepys MB, Hirschfield GM. C-Reactive Protein:a Critical Update. The
Journal of Clinical Investigation, Vol.111, 2003,p. 1805-1811.
Universitas Sumatera Utara
51
15. Indro Handojo. Imunoasai terapan pada beberapa penyakit infeksi.
Airlangga university press, 2004:274-275.
16. J.B.Henry. Clinical Diagnosis and Management by Laboratory Methods.
20th Edition. Saunders, Philadelphia, 2001, P. 259-262.
17. Roche Diagnostic GmbH. CRPHS. Roche diagnostics. Indianapolis. 2011.
P.1-4.
18. Meier-Ewert HK, Ridker PM, Rifai N. Absence of diurnal variation of Creactiveprotein concentrations in healthy human subjects.Clin Chem
2001;47: 426–430.
19. Eleni S. Nakou, Evangelos N. Liberopoulos et al. The Role of CReactiveProtein in Atherosclerotic Cardiovascular Disease: An Overview.
CurrentVascular Pharmacology. 2008; 6: 258-70.
20. Thomas A. Pearson, George A. Mensah. Markers of Inflammation and
Cardiovascular Disease. Application to Clinical and Public Health
Practice.A Statement for Healthcare Professionals From the Centers for
Disease Control and Prevention and the American Heart Association.
AHA/CDCScientific Statement. Circulation.
21. Rifai N, Ridker PM. High sensitive C-Reactive Protein: a Novel and
Promising Marker of Coronary Heart Disease.Clin Chem 2001;47:403–11.
22. Young JL, Libby P. Atherosclerosis. In Pathophysiology of Heart Disease.
Ed Lilly LS. Fourth Edition. Lippincott Williams & Wilkins. 2007. Page:
118-40.
Universitas Sumatera Utara
52
23. Libby. Prevention and Treatment of Atherosclerosis. In Harrison’s
Principles of Internal Medicine. Ed Kasper DL, et all. 17th Edition. Vol II.
Mc Graw Hill. 2009.Page 1430-3.
24. Kusmana D, Hanafi M. Patofisiologi Penyakit Jantung Koroner. Dalam:
Buku Ajar Kardiologi. Balai Penerbit FK UI. 1998 : 159-179.
25. Boudi. Non Coronary Atherosclerosis Overview of Atherosclerosis.
Medscape [Internet]. c2011 [online 21 Desember 2011; diakses 24 Juli
2013].
Dari:http://emedicine.medscape.com/article/1950759-
overview#showall.
26. Tugasworo,DodikPatogenesis Aterosklerosis. Semarang: Badan Penerbit
Universitas Diponegoro, 2010; 3-24.
27. Silbernagl, Stefan and Lang, Florian. Color Atlas of Pathophysiology
[ebook]. New York : Thieme. 2000; 236-239.
28. Hansson, GK. Inflammation, Atherosclerosis, and Coronary Artery
Disease [internet]. N Engl J Med. 2005 [diakses Juli 2013]; 352(16):168595. Dari: http://www.nejm.org/doi/full/10.1056/NEJMra043430.
29. Maiti R, Agrawal NK. Atherosclerosis in Diabetes Mellitus: Role of
Inflammation. Atherosclerosis in Diabetes Mellitus: Role of inflammation
[internet].
2007
[diakses
Juli
2013];
61:292-306.
Dari:
http://www.Indiajmedsci.org/article.asp.
30. Harrison's.ThePathogenesis,PreventionandTreatmentof
Atherosclerosis.
A.S. Principles of Internal Medicine, 17th ed [e-book]. New York :
McGraw-Hill. 2008; Chap. 235.
Universitas Sumatera Utara
53
31. American Heart Assocciation. Understand Your Risk of Heart Attack
[internet]. c2011 [online 21 Desember 2011;diakses 25 Juli 2013]. Dari:
http://www.heart.org/HEARTORG/Conditions/HeartAttack/UnderstandYou
r
Riskof
HeartAttack/Understand-Your-Risk-of-
HeartAttack_UCM_002040_Article. jsp#.Tyamr_mpH8d.
32. Naghavi M, Falk E, Hect HS, et al. From Vulnerable Plaque to Vulnerable
patient-Part III: Executive summary of the screening for heart Attack
prevention
and
Education
(SHAPE)
Task
Force
report.Am
j
Cardiol;98(2A):2H-15H.
33. Grossman, Ehud and Messerli, Franz H. Hypertension and Diabetes
[internet]. Adv Cardiol. 2008 [diakses Juli 2013]; 45:82-89. Dari:
content.karger.com/ ProdukteDB/Katalogteile/isbn3_8055/_84.
34. Ambrose. The Pathophysiology of Cigarette Smoking and Cardiovascular
Disease [internet]. J Am Coll Cardiol. 2004 [diakses Juli 2013]; 43(10):
1731-1737.Dari:
http://content.onlinejacc.org/cgi/content/full/43/10/1731/FIG1.
35. World Health Organization. Deaths from Coronary Heart Disease. 2008.
Available
from
http://www.who.int/mediacentre/factsheets/fs310/en/index.html.
36. Keung KS. Newsletter Carotid Intima-Media Thickness. Available at
http://www.hkbh.org.hk. April 2010.
37. Hurst RT et all. Scottsdale, Arizona. Clinical Use of Carotid Intima-Media
Thicknes : Review of Literature. Mayo Clinic. Journal of the American
Society of Echocardiography. July 2007.
Universitas Sumatera Utara
54
38. Cigna
Medical
Coverage
Policy.
Carotid
Intima-Media
Thicknes
Measurement. Available athttp:///www.cigna.com.2011.
39. Toboul PJ et all. Mannheim Carotid Intima-Media Thicknes Consensus
(2004-2006)
Consensus
Paper.
Cerebrovasc
Dis
2007;23:27-80.
Available at http://www.karger.com/ced.2007.
40. Yusmardi, Ketebalan Tunika Intima Media Arteri Karotis Komunis dengan
Derajat Stenosis Arteri Koroner pada pasien Angina Pektoris Stabil,
Departemen Penyakit Dalam FKUSU, 2013,7-9.
41. Vinayak Hegde and Ishmael Ching (2012). Vascular Inflammation: A New
Horizon in Cardiovascular RiskAssessment. In: Gasparyan A (Ed.).
Cardiovascular Risk Factors. In Tech,Ohio,2012, P. 103-140.
42. Osterud B, Bjorklid E. Role of Monocytes in Atherogenesis. American
Physiological Society, 2003, p. 83:1069-1112.
43. Nyandak T, Gogna A, Bansal S, Deb M. High Sensitive C-Reactive
Protein (hsCRP) and its Correlation with Angiographic Severity of
Coronary Artery Disease (CAD). JIACM. 2007;8(3):217-21.
44. Jalali BA, Rafie M, Mozaffari H. Lipoprotein(a) as a Strong risk factor for
Coronary Artery Disease in Iranian population. Medical Journal of Islamic.
2000:13; 5-9.
45. Yuliani F, Oenzil F, Iryani D. Hubungan berbagai faktor risiko terhadap
kejadian Penyakit Jantung Koroner pada penderitaDiabetes Mellitus tipe
2. Artikel Penelitian.Jurnal Kesehatan Andalas.2014; 3(1): 37-40.
Universitas Sumatera Utara
55
46. Matthias W. Lorenz et all, The
Carotid Atherosclerosis Progression
Study, Stroke Journal of American Heart Association, 7272 Greenville
avenue, Dallas, 2007.
47. David P Faxon, Valentin Fuster, Peter Libby, Joshua A. Beckman, William
R. Hiatt. Atherosclerotic Vascular Disease Conference : Writing Group III:
Pathophysiology, Circulation AHA 2004.
Universitas Sumatera Utara
DAFTAR PUSTAKA
1. Riskesdas 2007, Badan penelitian dan Pengembangan kesehatan
Departemen Kesehatan Republik Indonesia: Desember 2008.
2. Goran
K.
Hansson. Inflammation,
Atherosclerosis, and
Coronary
ArteryDisease. N Engl J Med 2005; 352: 1685-95.
3. Thomas A. Pearson, George A. Mensah. Markers of Inflammation
andCardiovascular Disease. Application to Clinical and Public Health
Practice. A Statement for Health care Professionals From the Centers for
Disease Control and Prevention and the American Heart Association.
AHA/CDC Scientific Statement. Circulation. 2003;107:499-511.
4. Syed Shahid Habib, Level of high-sensitivity c-reactive protein in Saudi
patients with chronic stable coronary artery disease. Department of
Physiology, College ofMedicine, King SaudiUniversity, Riyadh, Kingdom
of Saudi Arabia J Ayub Med Coll Abbottabad 2008;20(2).
5. Hansa, Gupta, Bhargava, Kartikeya, Bansal, Manish. Carotid IntimaMedia Thickness and Coronary Artery Disease: an Indian Perspective
[internet]. Asian Cardiovasc Thorac Ann. 2003 [diakses Januari 2012];
11:217221.Dari:http://asianannals.ctsnetjournals.org/cgi/content/full/11/3/217.
6. Kafetzakis, Alexandros, Kochiadakis, George and Lailotis, Anggelos.
Association of Subclinical Wall Changes of Carotid, Femoral, and
Popliteal Arteries With Obstructive Coronary Artery Disease in Patients
Undergoing Coronary Angiography [internet]. Chest. 2005 [diakses
Universitas Sumatera Utara
50
Januari2012].
128(4):2538-
43.Dari:http://chestjournal.chestpubs.org/content/128/4/2538.long.
7. Chien KL et all. Carotid Artery Intima-Media Thickness, Carotid Plaque
and Coronary Heart Disease and Stroke in Chinese. PloS ONE. Available
at: http//www.plosone.org. October 2008. Volume 3. Issue 10. E3435.
8. Chan SY et all. The Prognostic Importance of Endothelial Dysfunction and
Carotid Atheroma Burden in Patients with Coronary Artery Disease. J Am
Coll Cardiol 2003, 42:1037-1043.
9. Mirna M, Bachtiar M. Peranan Ultrasonografi dalam menilai kompleks
Intima-Media Arteri Karotis untuk diagnosis dini Aterosklerosis. Bagian
Radiologi FK Hasanuddin. Makasar. CDK 184/vol.38 no.3/April 2011.
10. Bratawidjaja KG. Imunologi Dasar. Gaya Baru. Edisi ke-7. Jakarta, 2006.
Hal. 13-15, 391-408.
11. Khera A. Biomarkers in Heart Diseases. In: Lemos JA (Ed). Biomarkers
in
Heart
Disease.
BlackWell
Publishing.
1st
Edition.
Massachussetts,2008,p.161-180.
12. Capuzzi DM, Freeman JS. C-Reactive Protein and Cardiovascular Risk in
the Metabolic Syndrome and Type 2 Diabetes, Clinical Diabetes, Vol.25,
2007, p. 16-22.
13. Lei KJ, Liu T, Zon G, Soravia E, Liu TY, Goldman ND. Genomic DNA
sequence for human C-reactive protein. J Biol Chem 1985;260:13377–83.
14. Pepys MB, Hirschfield GM. C-Reactive Protein:a Critical Update. The
Journal of Clinical Investigation, Vol.111, 2003,p. 1805-1811.
Universitas Sumatera Utara
51
15. Indro Handojo. Imunoasai terapan pada beberapa penyakit infeksi.
Airlangga university press, 2004:274-275.
16. J.B.Henry. Clinical Diagnosis and Management by Laboratory Methods.
20th Edition. Saunders, Philadelphia, 2001, P. 259-262.
17. Roche Diagnostic GmbH. CRPHS. Roche diagnostics. Indianapolis. 2011.
P.1-4.
18. Meier-Ewert HK, Ridker PM, Rifai N. Absence of diurnal variation of Creactiveprotein concentrations in healthy human subjects.Clin Chem
2001;47: 426–430.
19. Eleni S. Nakou, Evangelos N. Liberopoulos et al. The Role of CReactiveProtein in Atherosclerotic Cardiovascular Disease: An Overview.
CurrentVascular Pharmacology. 2008; 6: 258-70.
20. Thomas A. Pearson, George A. Mensah. Markers of Inflammation and
Cardiovascular Disease. Application to Clinical and Public Health
Practice.A Statement for Healthcare Professionals From the Centers for
Disease Control and Prevention and the American Heart Association.
AHA/CDCScientific Statement. Circulation.
21. Rifai N, Ridker PM. High sensitive C-Reactive Protein: a Novel and
Promising Marker of Coronary Heart Disease.Clin Chem 2001;47:403–11.
22. Young JL, Libby P. Atherosclerosis. In Pathophysiology of Heart Disease.
Ed Lilly LS. Fourth Edition. Lippincott Williams & Wilkins. 2007. Page:
118-40.
Universitas Sumatera Utara
52
23. Libby. Prevention and Treatment of Atherosclerosis. In Harrison’s
Principles of Internal Medicine. Ed Kasper DL, et all. 17th Edition. Vol II.
Mc Graw Hill. 2009.Page 1430-3.
24. Kusmana D, Hanafi M. Patofisiologi Penyakit Jantung Koroner. Dalam:
Buku Ajar Kardiologi. Balai Penerbit FK UI. 1998 : 159-179.
25. Boudi. Non Coronary Atherosclerosis Overview of Atherosclerosis.
Medscape [Internet]. c2011 [online 21 Desember 2011; diakses 24 Juli
2013].
Dari:http://emedicine.medscape.com/article/1950759-
overview#showall.
26. Tugasworo,DodikPatogenesis Aterosklerosis. Semarang: Badan Penerbit
Universitas Diponegoro, 2010; 3-24.
27. Silbernagl, Stefan and Lang, Florian. Color Atlas of Pathophysiology
[ebook]. New York : Thieme. 2000; 236-239.
28. Hansson, GK. Inflammation, Atherosclerosis, and Coronary Artery
Disease [internet]. N Engl J Med. 2005 [diakses Juli 2013]; 352(16):168595. Dari: http://www.nejm.org/doi/full/10.1056/NEJMra043430.
29. Maiti R, Agrawal NK. Atherosclerosis in Diabetes Mellitus: Role of
Inflammation. Atherosclerosis in Diabetes Mellitus: Role of inflammation
[internet].
2007
[diakses
Juli
2013];
61:292-306.
Dari:
http://www.Indiajmedsci.org/article.asp.
30. Harrison's.ThePathogenesis,PreventionandTreatmentof
Atherosclerosis.
A.S. Principles of Internal Medicine, 17th ed [e-book]. New York :
McGraw-Hill. 2008; Chap. 235.
Universitas Sumatera Utara
53
31. American Heart Assocciation. Understand Your Risk of Heart Attack
[internet]. c2011 [online 21 Desember 2011;diakses 25 Juli 2013]. Dari:
http://www.heart.org/HEARTORG/Conditions/HeartAttack/UnderstandYou
r
Riskof
HeartAttack/Understand-Your-Risk-of-
HeartAttack_UCM_002040_Article. jsp#.Tyamr_mpH8d.
32. Naghavi M, Falk E, Hect HS, et al. From Vulnerable Plaque to Vulnerable
patient-Part III: Executive summary of the screening for heart Attack
prevention
and
Education
(SHAPE)
Task
Force
report.Am
j
Cardiol;98(2A):2H-15H.
33. Grossman, Ehud and Messerli, Franz H. Hypertension and Diabetes
[internet]. Adv Cardiol. 2008 [diakses Juli 2013]; 45:82-89. Dari:
content.karger.com/ ProdukteDB/Katalogteile/isbn3_8055/_84.
34. Ambrose. The Pathophysiology of Cigarette Smoking and Cardiovascular
Disease [internet]. J Am Coll Cardiol. 2004 [diakses Juli 2013]; 43(10):
1731-1737.Dari:
http://content.onlinejacc.org/cgi/content/full/43/10/1731/FIG1.
35. World Health Organization. Deaths from Coronary Heart Disease. 2008.
Available
from
http://www.who.int/mediacentre/factsheets/fs310/en/index.html.
36. Keung KS. Newsletter Carotid Intima-Media Thickness. Available at
http://www.hkbh.org.hk. April 2010.
37. Hurst RT et all. Scottsdale, Arizona. Clinical Use of Carotid Intima-Media
Thicknes : Review of Literature. Mayo Clinic. Journal of the American
Society of Echocardiography. July 2007.
Universitas Sumatera Utara
54
38. Cigna
Medical
Coverage
Policy.
Carotid
Intima-Media
Thicknes
Measurement. Available athttp:///www.cigna.com.2011.
39. Toboul PJ et all. Mannheim Carotid Intima-Media Thicknes Consensus
(2004-2006)
Consensus
Paper.
Cerebrovasc
Dis
2007;23:27-80.
Available at http://www.karger.com/ced.2007.
40. Yusmardi, Ketebalan Tunika Intima Media Arteri Karotis Komunis dengan
Derajat Stenosis Arteri Koroner pada pasien Angina Pektoris Stabil,
Departemen Penyakit Dalam FKUSU, 2013,7-9.
41. Vinayak Hegde and Ishmael Ching (2012). Vascular Inflammation: A New
Horizon in Cardiovascular RiskAssessment. In: Gasparyan A (Ed.).
Cardiovascular Risk Factors. In Tech,Ohio,2012, P. 103-140.
42. Osterud B, Bjorklid E. Role of Monocytes in Atherogenesis. American
Physiological Society, 2003, p. 83:1069-1112.
43. Nyandak T, Gogna A, Bansal S, Deb M. High Sensitive C-Reactive
Protein (hsCRP) and its Correlation with Angiographic Severity of
Coronary Artery Disease (CAD). JIACM. 2007;8(3):217-21.
44. Jalali BA, Rafie M, Mozaffari H. Lipoprotein(a) as a Strong risk factor for
Coronary Artery Disease in Iranian population. Medical Journal of Islamic.
2000:13; 5-9.
45. Yuliani F, Oenzil F, Iryani D. Hubungan berbagai faktor risiko terhadap
kejadian Penyakit Jantung Koroner pada penderitaDiabetes Mellitus tipe
2. Artikel Penelitian.Jurnal Kesehatan Andalas.2014; 3(1): 37-40.
Universitas Sumatera Utara
55
46. Matthias W. Lorenz et all, The
Carotid Atherosclerosis Progression
Study, Stroke Journal of American Heart Association, 7272 Greenville
avenue, Dallas, 2007.
47. David P Faxon, Valentin Fuster, Peter Libby, Joshua A. Beckman, William
R. Hiatt. Atherosclerotic Vascular Disease Conference : Writing Group III:
Pathophysiology, Circulation AHA 2004.
Universitas Sumatera Utara